These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11410933)

  • 1. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders.
    Singh MM
    Med Res Rev; 2001 Jul; 21(4):302-47. PubMed ID: 11410933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scoping review to map evidence on mechanism of action, pharmacokinetics, effectiveness and side effects of centchroman as a contraceptive pill.
    Kabra R; Allagh KP; Ali M; Jayathilaka CA; Mwinga K; Kiarie J
    BMJ Open; 2019 Oct; 9(10):e030373. PubMed ID: 31594884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concurrently coadministered drugs on the pharmacokinetic/pharmacodynamic profile of centchroman, a nonsteroidal oral contraceptive, in rats.
    Kumar V; Lal J; Singh MM; Gupta RC
    Contraception; 2006 Aug; 74(2):165-73. PubMed ID: 16860055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centchroman: A safe reversible postcoital contraceptive with curative and prophylactic activity in many disorders.
    Kamboj VP; Ray S; Anand N
    Front Biosci (Elite Ed); 2018 Jan; 10(1):1-14. PubMed ID: 28930603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics and interaction of centchroman--a mini review.
    Lal J
    Contraception; 2010 Apr; 81(4):275-80. PubMed ID: 20227542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction with anti-implantation and estrogen antagonistic activities of dl-ormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats.
    Ghosh R; Kamboj VP; Singh MM
    Contraception; 2001 Oct; 64(4):261-9. PubMed ID: 11747877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
    Dwivedi A; Basu R; Chowdhury SR; Goyal N
    Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-related effects of a triphenylethylene antiestrogen on estrogen-induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in rats.
    Trivedi RN; Chauhan SC; Dwivedi A; Kamboj VP; Singh MM
    Contraception; 1995 Jun; 51(6):367-79. PubMed ID: 7554978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of acceptability, safety, and continuation rates of centchroman as postabortion nonsteroidal contraceptive pill.
    Agarwal K; Dewan R
    Contraception; 2023 May; 121():109961. PubMed ID: 36736648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of interaction potential of certain concurrently administered drugs with pharmacological and pharmacokinetic profile of centchroman in rats.
    Khurana M; Lal J; Singh MM; Paliwal JK; Kamboj VP; Gupta RC
    Contraception; 2002 Jul; 66(1):47-56. PubMed ID: 12169381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory influence of oral contraceptives on mammary growth pattern of normal and ovariectomised mice.
    Ecavade A; Rao AR
    Contraception; 1994 Aug; 50(2):175-83. PubMed ID: 7956216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and pharmacokinetics of centchroman. A new nonsteroidal postcoital contraceptive agent and its 7-desmethyl metabolite in female rats after a single oral dose.
    Paliwal JK; Gupta RC
    Drug Metab Dispos; 1996 Feb; 24(2):148-55. PubMed ID: 8742225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature of estrogenic and anti-estrogenic actions of centchroman on rat uterus.
    Roy S; Datta JK
    Contraception; 1976 May; 13(5):597-604. PubMed ID: 1261262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of centchroman on cellular and humoral immunity.
    Thomas L; Asad M; Hrishikeshavan HJ; Chandrakala GK
    Indian J Physiol Pharmacol; 2007; 51(4):387-94. PubMed ID: 18476393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural effects of the nonsteroidal contraceptive centchroman on rat uterine luminal epithelium in early pregnancy.
    Mehrotra PK; Nilsson BO
    Int J Fertil; 1984; 29(1):44-53. PubMed ID: 6146584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centchroman: is unsupervised long-term use warranted? Case report.
    Malhotra KP; Sherpa M; Bhatia A
    Eur J Contracept Reprod Health Care; 2011 Oct; 16(5):403-6. PubMed ID: 21777048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centchroman: a new non-steroidal oral contraceptive in human milk.
    Gupta RC; Paliwal JK; Nityanand S; Asthana OP; Lal J
    Contraception; 1995 Nov; 52(5):301-5. PubMed ID: 8585887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigestagenic activity of Ixora finlaysoniana in rat.
    Singh MM; Chowdhury SR; Kulshreshtha DK; Kamboj VP
    Contraception; 1993 Aug; 48(2):178-91. PubMed ID: 8403914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centchroman inhibits proliferation of head and neck cancer cells through the modulation of PI3K/mTOR pathway.
    Srivastava VK; Gara RK; Bhatt ML; Sahu DP; Mishra DP
    Biochem Biophys Res Commun; 2011 Jan; 404(1):40-5. PubMed ID: 21094138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostanoid mediated effects of centchroman, a non-steroidal oral contraceptive.
    Srivastava R; Puri V; Srimal RC; Dhawan BN
    Agents Actions; 1986 Aug; 18(5-6):596-9. PubMed ID: 3532722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.